Publisher Full Text
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?Eur Heart J. 2020 05 14; 41(19):1801-1803.EH
Links
Pub Type(s)
Journal Article
Language
eng
PubMed ID
32196087
Clinical Trial Links
Citation
Kuster, Gabriela M., et al. "SARS-CoV2: Should Inhibitors of the Renin-angiotensin System Be Withdrawn in Patients With COVID-19?" European Heart Journal, vol. 41, no. 19, 2020, pp. 1801-1803.
Kuster GM, Pfister O, Burkard T, et al. SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J. 2020;41(19):1801-1803.
Kuster, G. M., Pfister, O., Burkard, T., Zhou, Q., Twerenbold, R., Haaf, P., Widmer, A. F., & Osswald, S. (2020). SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? European Heart Journal, 41(19), 1801-1803. https://doi.org/10.1093/eurheartj/ehaa235
Kuster GM, et al. SARS-CoV2: Should Inhibitors of the Renin-angiotensin System Be Withdrawn in Patients With COVID-19. Eur Heart J. 2020 05 14;41(19):1801-1803. PubMed PMID: 32196087.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
AU - Kuster,Gabriela M,
AU - Pfister,Otmar,
AU - Burkard,Thilo,
AU - Zhou,Qian,
AU - Twerenbold,Raphael,
AU - Haaf,Philip,
AU - Widmer,Andreas F,
AU - Osswald,Stefan,
PY - 2020/03/11/received
PY - 2020/03/14/revised
PY - 2020/3/21/pubmed
PY - 2020/3/21/medline
PY - 2020/3/21/entrez
SP - 1801
EP - 1803
JF - European heart journal
JO - Eur Heart J
VL - 41
IS - 19
SN - 1522-9645
UR - https://www.unboundmedicine.com/medline/citation/32196087/full_citation
L2 - https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehaa235
DB - PRIME
DP - Unbound Medicine
ER -